Biotech companies with operations in California, home to one third of the nation’s biotech firms, spent about $40 million in federal lobbying between 2009 and 2011. Nationwide, pharmaceutical, medical device and biotech industries spent a total of $700 million on campaign contributions and on lobbying Congress and the Obama administration during those three years, reports KGO-TV in San Francisco.
